> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA OKs Avita Recell System PMA Supplement
- URL: https://www.fdaweb.com/fda-oks-avita-recell-system-pma-supplement/
- Published: 2022-02-17T12:00:00.000Z
- Updated: 2026-09-14T17:33:03.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5151192

FDA has approved a PMA supplement application for an improved version of Avita Medical’s Recell autologous cell harvesting device system. The company [says](https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=newssearch&cd=&cad=rja&uact=8&ved=2ahUKEwiyru2g2of2AhVTmIkEHWdxA60QxfQBKAB6BAgOEAI&url=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2022%2F02%2F17%2F2387555%2F0%2Fen%2FAVITA-Medical-Announces-FDA-Approval-of-New-RECELL-System-with-Improved-Ease-of-Use.html&usg=AOvVaw3S2XONeJQc7WsHtm1xJyHc) the revisions will give clinicians a more efficient user experience and simplified workflow. The Recell system enables healthcare professionals to produce a suspension of Spray-On-Skin cells using a small sample of a patient’s skin to treat acute thermal burns.